Literature DB >> 4314119

Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-1, in chick intestinal nuclei.

D E Lawson, P W Wilson, E Kodicek.   

Abstract

1. A comparison was made of the nature and intestinal intracellular distribution of the metabolites formed in vitamin D-deficient chicks from [4-(14)C]cholecalciferol and [1-(3)H]cholecalciferol. 2. The simultaneous administration of the two radioactive substances showed the presence in blood, liver, intestine, kidney and bone of cholecalciferol, its ester, 25-hydroxycholecalciferol and a further metabolite of cholecalciferol more polar than 25-hydroxycholecalciferol. The (3)H/(14)C ratios in these four radioactive components were the same as that of the dosed material (4.7:1) with the exception of the most polar material. The (3)H/(14)C ratio was lower in the fourth, most polar, metabolite (0.4:1-1.8:1) in all tissues examined, with the exception of blood. 3. In the chick intestine the polar metabolite accounted for almost 70% of the radioactivity in this tissue after a dose of 0.5mug. of [4-(14)C,1-(3)H]cholecalciferol. This polar metabolite from the intestine also had the lowest (3)H/(14)C ratio of all the tissues. It appears that in the chick intestine the polar metabolite reaches a maximum concentration of 1ng./g. of tissue, above which it cannot be increased irrespective of the dose of the vitamin. 4. The intestinal intracellular organelle with the highest concentration of (14)C radioactivity is the nucleus, and this radioactivity is almost entirely due to the polar metabolite with the lowered (3)H/(14)C ratio, in this case <0.2:1. It appears to be further localized in the chromatin of the nuclei. However, about half of the polar metabolite in the intestine is extranuclear. 5. Double-labelled 25-hydroxycholecalciferol was prepared and after its administration to vitamin D-deficient chicks the polar metabolite with the lowered (3)H/(14)C ratio was detected in liver, kidney, intestine, bone, muscle and heart. 6. None of the polar metabolite with the lowered (3)H/(14)C ratio was detected 16hr. after dosing with either the double-labelled vitamin or the double-labelled 25-hydroxycholecalciferol in blood and adipose tissue of vitamin D-deficient chicks, nor in the intestine, liver and kidney of supplemented birds. 7. The reasons for this loss of (3)H relative to (14)C are discussed in relation to possible chemical structures of this new polar metabolite.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4314119      PMCID: PMC1185099          DOI: 10.1042/bj1150269

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  THE PREPARATION OF H3-VITAMINS D2 AND D3--THEIR LOCALIZATION IN THE RAT.

Authors:  A W NORMAN; H F DELUCA
Journal:  Biochemistry       Date:  1963 Sep-Oct       Impact factor: 3.162

2.  BIOLOGICALLY ACTIVE FORMS OF VITAMIN D3 IN KIDNEY AND INTESTINE.

Authors:  A W NORMAN; J LUND; H F DELUCA
Journal:  Arch Biochem Biophys       Date:  1964-10       Impact factor: 4.013

3.  The biosynthesis of 14C-labelled ergocalciferol.

Authors:  E KODICEK
Journal:  Biochem J       Date:  1955-05-14       Impact factor: 3.857

4.  Metabolism of tritiated vitamin D.

Authors:  R K Callow; E Kodicek; G A Thompson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-02-15

5.  New vitamin D metabolite localized in intestinal cell nuclei.

Authors:  D E Lawson; P W Wilson; E Kodicek
Journal:  Nature       Date:  1969-04-12       Impact factor: 49.962

6.  The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat.

Authors:  P F Neville; H F DeLuca
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

7.  The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo.

Authors:  M R Haussler; J F Myrtle; A W Norman
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

8.  Subcellular location of vitamin D and its metabolites in intestinal mucosa after a 10-IU dose.

Authors:  S J Stohs; H F DeLuca
Journal:  Biochemistry       Date:  1967-11       Impact factor: 3.162

9.  The intracellular distribution of [1-3H]cholecalciferol in the intestine of vitamin D-deficient and -supplemented rats.

Authors:  P W Wilson; D E Lawson; E Kodicek
Journal:  Biochem J       Date:  1967-04       Impact factor: 3.857

10.  Isolation of chick intestinal nuclei. Effect of vitamin D3 on nuclear metabolism.

Authors:  D E Lawson; P W Wilson; D C Barker; E Kodicek
Journal:  Biochem J       Date:  1969-11       Impact factor: 3.857

View more
  29 in total

Review 1.  Vitamin D metabolism. Recent advances.

Authors:  T C Stamp
Journal:  Arch Dis Child       Date:  1973-01       Impact factor: 3.791

2.  Mechanism of action of 1,25-dihydroxycholecalciferol on intestinal calcium transport.

Authors:  Y Tanaka; H F DeLuca; J Omdahl; M F Holick
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

3.  Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine.

Authors:  M F Holick; H K Schnoes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

4.  Metabolism of 25-hydroxycholecalciferol in nephrectomized rats.

Authors:  K Schaefer; D von Herrath; H U Koch; A Opitz; R Stratz
Journal:  Klin Wochenschr       Date:  1971-06-15

5.  The response of the small intestine to vitamin D. Isolation and properties of chick intestinal polyribosomes.

Authors:  J S Emtage; D E Lawson; E Kodicek
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

Review 6.  Recent advances in the unerstanding and management of metabolic bone disease.

Authors:  R Smith
Journal:  Proc R Soc Med       Date:  1970-09

7.  The stimulation of 1,25-dihydroxycholecalciferol metabolism in vitamin D-deficient rats by 1,25-dihydroxycholecalciferol treatment.

Authors:  C A Frolik; H F DeLuca
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.

Authors:  R G Wong; A W Norman; C R Reddy; J W Coburn
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

9.  Stimulation of creatine kinase BB activity by 1 alpha,25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol in rat tissues.

Authors:  D Sömjen; Y Weisman; I Binderman; A M Kaye
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

10.  Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats.

Authors:  M J Favus; M W Walling; D V Kimberg
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.